Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 June 2020 | Story Communication and Marketing

Due to the seriousness of the global COVID-19 outbreak, the Rector and Vice-Chancellor, Prof Francis Petersen, established a Coronavirus Task Team comprising representatives from various key function areas on the University of the Free State (UFS) campuses. This includes members of the executive management, virologists, infectious disease experts, and representatives of the academic and support-service functions. The team meets frequently to discuss the contingency and preparedness plans for the university’s three campuses. 

In response to the current pandemic, the UFS has opted to postpone all graduation and related prize-giving ceremonies scheduled to take place from 20 to 24 April 2020 and 10 to 12 June 2020 on the Bloemfontein Campus,  as well as those from 8 to 9 May 2020 on the Qwaqwa Campus. We know that this was the best decision to curb the spread of the disease as far as possible.

The university acknowledges the importance of graduation ceremonies and appreciates the diligence displayed by our students. We also recognise the virtual graduation ceremonies held by other institutions to confer and award qualifications. As such, a survey was issued to the April, May, and June 2020 graduates to determine their preference between virtual and traditional ceremonies.  

We are grateful for the response to the survey, which indicated that the overwhelming majority of graduates prefer a traditional graduation ceremony. The university’s executive management subsequently resolved that a final decision regarding virtual or traditional ceremonies would be made towards the end of July or the beginning of August 2020. The university still hopes to host the graduation ceremonies on its campuses in 2020 so that we can celebrate this joyous occasion with our graduates and their families. We will continue to evaluate the decision in light of the developments related to COVID-19, as well as taking into account the national lockdown level at the time. 

We will continue to support and assist students who require confirmation of their qualification and academic records for either employment or to further their studies.  Please contact us at 051 401 9666 or studentadmin@ufs.ac.za for any enquiries about the graduation ceremonies.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept